A detailed history of Bank Of Nova Scotia transactions in Jazz Pharmaceuticals PLC stock. As of the latest transaction made, Bank Of Nova Scotia holds 3,329 shares of JAZZ stock, worth $404,972. This represents 0.0% of its overall portfolio holdings.

Number of Shares
3,329
Previous 22,100 84.94%
Holding current value
$404,972
Previous $2.36 Million 84.27%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$100.57 - $116.37 $1.89 Million - $2.18 Million
-18,771 Reduced 84.94%
3,329 $371,000
Q2 2024

Aug 14, 2024

SELL
$103.94 - $118.98 $2.59 Million - $2.96 Million
-24,913 Reduced 52.99%
22,100 $2.36 Million
Q1 2024

May 14, 2024

BUY
$115.19 - $132.77 $4.13 Million - $4.76 Million
35,860 Added 321.53%
47,013 $5.66 Million
Q4 2023

Feb 12, 2024

BUY
$114.26 - $136.0 $1.08 Million - $1.29 Million
9,478 Added 565.85%
11,153 $1.37 Million
Q3 2023

Nov 14, 2023

SELL
$122.0 - $145.31 $548,634 - $653,459
-4,497 Reduced 72.86%
1,675 $216,000
Q2 2023

Aug 03, 2023

BUY
$122.5 - $147.16 $75,215 - $90,356
614 Added 11.05%
6,172 $765,000
Q1 2023

May 11, 2023

BUY
$133.98 - $160.47 $204,185 - $244,556
1,524 Added 37.78%
5,558 $813,000
Q4 2022

Feb 09, 2023

SELL
$129.72 - $159.85 $28.9 Million - $35.6 Million
-222,787 Reduced 98.22%
4,034 $642,000
Q3 2022

Nov 10, 2022

BUY
$126.59 - $161.18 $12.1 Million - $15.4 Million
95,769 Added 73.08%
226,821 $30.2 Million
Q2 2022

Aug 08, 2022

BUY
$141.59 - $168.66 $18.6 Million - $22.1 Million
131,052 New
131,052 $20.4 Million
Q2 2022

Aug 05, 2022

SELL
$141.59 - $168.66 $4.86 Million - $5.79 Million
-34,324 Closed
0 $0
Q1 2022

May 09, 2022

SELL
$129.64 - $160.7 $3.42 Million - $4.24 Million
-26,366 Reduced 43.44%
34,324 $5.34 Million
Q4 2021

Feb 11, 2022

BUY
$119.87 - $145.67 $7.27 Million - $8.84 Million
60,690 New
60,690 $7.73 Million

Others Institutions Holding JAZZ

About Jazz Pharmaceuticals plc


  • Ticker JAZZ
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,680,700
  • Market Cap $7.63B
  • Description
  • Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...
More about JAZZ
Track This Portfolio

Track Bank Of Nova Scotia Portfolio

Follow Bank Of Nova Scotia and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of Nova Scotia, based on Form 13F filings with the SEC.

News

Stay updated on Bank Of Nova Scotia with notifications on news.